debrisoquine (Compound)

Synonyms:Debrisoquine, Debrisoquin, 1131-64-2, Debrisochinum, Isocaramidine, Debrisoquina, Debrisoquinum, 3,4-dihydroisoquinoline-2(1H)-carboximidamide, DEBRISOQUIN SULFATE, Declinax, Equitonil, 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, Isocaramidine sulfate, 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine, Debrisoquin hemisulfate, 3,4-dihydro-1H-isoquinoline-2-carboximidamide, 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide, 2(1H)-Isoquinolinecarboximidamide,3,4-dihydro-, Debrisoquine; Isocaramidine, Debrisoquin-13C,15N2 Hemisulfate, CHEMBL169901, X31CDK040E, CHEBI:34665, 1,2,3,4-tetrahydroisoquinoline-2-carboximidamide, Debrisoquinum [INN-Latin], Debrisoquina [INN-Spanish], Debrisoquine [INN:BAN], Ro 5-3307/1, 1246814-89-0, 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1), NSC139330, SR-01000075159, NCGC00016513-01, CAS-581-88-4, EINECS 214-470-1, UNII-X31CDK040E, 3,4-Dihydro-2(1H)-isoquinoline carboxamidine sulfate, 3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXAMIDINE, 2-Amidino-1,2,3,4-tetrahydroisoquinoline, DEBRISOQUIN [MI], Prestwick0_000372, Prestwick1_000372, Prestwick2_000372, Prestwick3_000372, DEBRISOQUINE [INN], Lopac0_000326, BSPBio_000523, DEBRISOQUINE [WHO-DD], SCHEMBL309184, SPBio_002444, BPBio1_000577, DTXSID7022885, 1,2,3, 4-Tetrahydro-isoquinoline-2-carboxamidine sulfate, HMS2089P09, 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1), BCP18785, BDBM50122613, MFCD00865904, STK232096, AKOS000225362, BS-3952, DB04840, SDCCGSBI-0206944.P002, Sulfuric acid compound with 3,4-dihydro-2(1H)-isoquinolinecarboximidamide (1:1), NCGC00016513-02, NCGC00016513-03, SBI-0206944.P001, FT-0691983, EN300-8045934, 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide #, Q3704421, SR-01000075159-1, SR-01000075159-4, 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro- (7CI,8CI)

Pubchem:PUBCHEM:73707358

Id:960296a9-88b1-5284-a62b-002b85ed3ee0

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View debrisoquine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for debrisoquine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with debrisoquine.

Results found

Linked to

	Label	Description
	debrisoquine (bf5171d0-9164-4a81-92b6-7a9984c5c2f3) Collection (Entity type)	Metadatata for debrisoquine
	DCSTRUCT ID 00788 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00788; PubChem_CID:2966, FILE=drugcentral_drug_00788.json)
	BRD-K80419150-065-03-7 Substance (Entity type)	A Substance
	debrisoquin negatively regulates IKZF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquine negatively regulates HMG20B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquin negatively regulates ITGAE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquine negatively regulates TPBG Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquine positively regulates GNA11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquine positively regulates KAZN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	debrisoquine positively regulates DNAJA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS